Pulmonx Operating Expenses 2019-2025 | LUNG

Pulmonx operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Pulmonx Annual Operating Expenses
(Millions of US $)
2024 $141
2023 $131
2022 $112
2021 $96
2020 $65
2019 $50
2018 $35
Pulmonx Quarterly Operating Expenses
(Millions of US $)
2025-03-31 $37
2024-12-31 $37
2024-09-30 $35
2024-06-30 $36
2024-03-31 $33
2023-12-31 $33
2023-09-30 $33
2023-06-30 $34
2023-03-31 $31
2022-12-31 $30
2022-09-30 $27
2022-06-30 $28
2022-03-31 $26
2021-12-31 $26
2021-09-30 $23
2021-06-30 $25
2021-03-31 $22
2020-12-31 $19
2020-09-30 $16
2020-06-30 $15
2020-03-31 $15
2019-12-31
2019-09-30 $13
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.124B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.731B 53.50
Hims & Hers Health (HIMS) United States $11.944B 124.09
Tempus AI (TEM) United States $11.403B 0.00
IRhythm Technologies (IRTC) United States $4.673B 0.00
Inspire Medical Systems (INSP) United States $4.222B 65.97
Privia Health (PRVA) United States $2.843B 194.33
Enovis (ENOV) United States $1.910B 10.65
Clover Health Investments (CLOV) United States $1.634B 0.00
Schrodinger (SDGR) United States $1.578B 0.00
Phreesia (PHR) United States $1.484B 0.00
Omnicell (OMCL) United States $1.387B 24.47
Azenta (AZTA) United States $1.269B 58.98
10x Genomics (TXG) United States $1.058B 0.00
Butterfly Network (BFLY) United States $0.626B 0.00
Fulgent Genetics (FLGT) United States $0.615B 0.00
Talkspace (TALK) United States $0.494B 147.50
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.391B 0.00
TruBridge (TBRG) United States $0.361B 801.00
Outset Medical (OM) United States $0.333B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.32
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00